As cell therapies continue to advance, the need for better automated, large-scale manufacturing options increases.

This year’s Nobel prize in physiology or medicine has been awarded to Victor Ambros and Gary Ruvkun for their groundbreaking ...

The current status of the Biosecure Act is that it was passed ​ by the US House of Representatives on Sep 9, with a vote of 306-81 for the bill across both parties. It is now awaiting a vote by the US ...

The UK cell therapy biotech will now advance its first candidate cell therapy to clinical trials for treatment of liver ...

The newly opened Biotech Center of Excellence will be dedicated to developing and producing biological drugs, housing the ...

Rebekah's father passed on his passion for science and problem solving to her and much her of childhood was spent doing fun ...

The significant advantages it offers include: Large reduction in COGS: By 2025, EnzeneX 2.0 expects to produce 40 kg/1000 L batches at $40/gram, redefining FCCM economics. Lower operational costs and ...

At this October’s CPHI event being held in Milan, dsm-firmenich, is inviting stakeholders across the pharmaceutical market to immerse themselves in its patient-inspired innovations. Located at booth ...

As CPHI Milan 2024 approaches, Symbiosis Pharmaceutical Services is gearing up to showcase major expansions and innovations in sterile biopharmaceutical manufacturing. The event provides a great ...

The company will introduce its innovative siliconized moulded glass vials, positioning itself as the only global supplier offering this technology to pharmaceutical standards. These siliconized vials ...